Edwards Lifesciences Corporation (NYSE:EW) Q1 2019 Earnings Conference Call April 23, 2019 5:00 PM ET Company Participants Mike Mussallem - Chairman & CEO Scott Ullem - CFO Conference Call Participants Vijay Kumar - Evercore ISI David Lewis - Morgan Stanley Bob Hopkins - Bank of America Merrill Lynch Lawrence Biegelsen - Wells Fargo Chris Pasquale - Guggenheim Robbie Marcus - J.P. Morgan Rick Wise - Stifel Joanne Wuensch - BMO Capital Markets Jason Mills - Canaccord Genuity Matt Taylor - UBS Josh Jennings - ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-4316614 (St ...

| --- | --- | |-------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | Edwards Lifesciences Patient-Focused Innovations for Structural Heart Disease and Critical Care Monitoring | | Cautionary Statement Presentations and comments made today by the management of Edwards Lifesciences Corporation will include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securit ...